|
Quotes & Info
|
| MDRX > SEC Filings for MDRX > Form 8-K/A on 31-Dec-2008 | All Recent SEC Filings |
31-Dec-2008
Regulation FD Disclosure, Financial Statements and
Allscripts-Misys included as Exhibit 99.3 to Amendment No. 2, filed with the Securities and Exchange Commission ("SEC") on November 24, 2008, to Current Report on Form 8-K filed by Allscripts-Misys with the SEC on October 17, 2008, non-GAAP summary quarterly information for each of the four quarters in the year ended May 31, 2008 and for the three months ended August 31, 2008, combining the results of operations of Allscripts and MHS. This Amendment No. 3 is being filed by Allscripts-Misys to correct an error in the first quarter of fiscal 2009 reconciliation to combined non-GAAP net income in double counting the gain on sale of the Physicians Interactive business unit of $2.0 million. The effect of this will be an increase in combined non-GAAP net income to $15.4 million rather than the $13.4 million previously reported.
Attached as Exhibit 99.3 is non-GAAP summary quarterly information for each of the four quarters in the year ended May 31, 2008 and for the three months ended August 31, 2008, combining the results of operations of Allscripts and MHS. The information furnished under this Item 7.01, including Exhibit 99.3 attached hereto, shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing. This Report will not be deemed an admission as to the materiality of any information in this Report that is being disclosed pursuant to Regulation FD.
(d) Exhibits.
Exhibit 99.3 Non-GAAP summary quarterly information for each of the four
quarters in the year ended May 31, 2008 and for the three months
ended August 31, 2008, combining the results of operations of
Allscripts and MHS.
|
|
|